Project Grant HT94252410937
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$812K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94158, USA
Similar Awards
The Department of the Army Medical Command awarded a $751,936 Project Grant to the J. David Gladstone Institutes located in San Francisco, California. The grant period runs from September 26, 2022 through September 25, 2025. The grant supports research into the "Impact of Energy Failure on Alpha-Synuclein Spread and Neurodegeneration" under the Military Medical Research and Development program (CFDA 12.420). This program aims to transform military and public health through innovative...
This federal Project Grant award of $1,021,409.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program will support research at the University of Illinois to investigate the underlying neurobiology of non-motor symptoms in Parkinson's disease. The research aims to elucidate the role of serotonin system plasticity in the development of these disabling non-motor complications, which can include cognitive, psychiatric, and...
This federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,493,233 to The Trustees of Columbia University in the City of New York to fund research on gene therapy in a nonhuman primate model of cognitive defects in Parkinson's disease. The award commenced on November 15, 2024 and is set to be completed by November 14, 2027. The university's Health Sciences Division will leverage its...
This federal Project Grant award of $673,448.00, provided by the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research focused on transforming healthcare for military service members and the broader public. The award was granted to The Research Foundation For The State University Of New York (RF SUNY) to conduct research on the "MALADAPTIVE 5-HT RAPHE-CORTICOLIMBIC PLASTICITY UNDERLYING THE...
The federal Project Grant award of $2,000,000.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) will support research conducted by the University of Nebraska Medical Center (UNMC) to investigate the interrelationship between the PINK1-PRKN pathway disruption and tauopathy in the pathophysiology of cognitive impairment in Parkinson's disease. The research project aims to advance the understanding of these complex neurological mechanisms, with...
This $1,199,967 Project Grant awarded on September 1, 2023 by the Defense Health Agency supports research under the Military Medical Research and Development (CFDA 12.420) program. The primary award recipient, the University of Vermont & State Agricultural College, will investigate "Cognitive Functions Impairment as a Novel Paradigm for Delineating Cognitive Dysfunction in Parkinson's Disease". Two sub-awards were made to Case Western Reserve University and the Portland VA Research...
This $997,008 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports a 3-year research project by the Northern California Institute for Research and Education, Inc. (NCIRE) to investigate risk and resilience factors for Alzheimer's disease and related dementias (ADRD) among American Indian and Alaskan Native veterans. The research aims to inform prevention strategies for this population. NCIRE is a...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $813,085 to the Mayo Clinic Jacksonville, a nonprofit healthcare and research institution, to resolve the critical role of PINK1 expression and activity in Parkinson's disease pathophysiology and explore therapeutic interventions. The 3-year research project, commencing on June 1, 2025 and concluding on May 31, 2028, aims to advance the scientific...
The Cleveland Clinic Foundation will receive $400,000 from the Defense Health Agency under a two-year Project Grant award through the Military Medical Research and Development program (CFDA 12.420). The grant will support research from July 1, 2023 to June 30, 2025 to investigate the role of microglia and the NLRP3 inflammasome in contributing to non-motor deficits associated with Parkinson's disease. The Military Medical Research and Development program aims to transform military and public...
The Department of the Army Medical Command awarded a $1.4 million project grant to The Children's Hospital of Philadelphia Research Institute through the Military Medical Research and Development program. The three-year grant will fund research into the genetic and environmental influences on the pathogenesis of Parkinson's disease by investigating young adult brain and behavioral risk indicators. The Military Medical Research and Development program aims to advance biomedical research that...